State Medicaid Expansions and Mortality, Revisited: A Cost-Benefit Analysis
Author(s) -
Benjamin D. Sommers
Publication year - 2017
Publication title -
american journal of health economics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.89
H-Index - 12
eISSN - 2332-3507
pISSN - 2332-3493
DOI - 10.1162/ajhe_a_00080
Subject(s) - medicaid , demography , propensity score matching , mortality rate , medicine , actuarial science , gerontology , health care , statistics , economics , sociology , mathematics , economic growth
Previous research found that Medicaid expansions in New York, Arizona, and Maine in the early 2000s reduced mortality. I revisit this question with improved data and methods, exploring distinct causes of death and presenting a cost-benefit analysis. Differences-in-differences analysis using a propensity score control group shows that all-cause mortality declined by 6 percent, with the most robust reductions for health-care amenable causes. HIV-related mortality (affected by the recent introduction of antiretrovirals) accounted for 20 percent of the effect. Mortality changes were closely linked to county-level coverage gains, with one life saved annually for every 239 to 316 adults gaining insurance. The results imply a cost per life saved ranging from $327,000 to $867,000 which compares favorably with most estimates of the value of a statistical life.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom